This randomized , double-blind , placebo-controlled trial evaluated MR calcifediol in CKD subjects ( n = 78 ) with plasma intact parathyroid hormone ( iPTH ) > 70 pg/ml and serum total 25-hydroxyvitamin D < 30 ng/ml .